Pharming Group N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 21 oct 2020 - 07:07
  • Statutory name Pharming Group N.V.
  • Title Pharming receives Orphan Drug Designation from the European Commission for leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS)

Related downloads

202010210000000002_38135091-PR Leniolisib ODD 20OCT2020 final.docx

Date last update: 02 December 2020

Share information

Share on: Share this